Patent assignee · US · COMPANY

Mitobridge, Inc.

20Patents
20Active
20Granted
51Portfolio score

Filing activity: Oct 2, 2015 → Sep 26, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US9938234B2 PPAR agonists Chemistry; Metallurgy 12 Active
US10766888B1 HMOX1 inducers Chemistry; Metallurgy 10 Active
US10479775B1 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 6 Active
US10399958B2 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 6 Active
US10927094B2 Crystalline and salt forms of PPAR agonist compounds Chemistry; Metallurgy 3 Active
US11578052B2 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 1 Active
US11530192B2 Crystalline and salt forms of PPAR agonist compounds Chemistry; Metallurgy 1 Active
US10611790B2 Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases Human Necessities 1 Active
US10550071B2 PPAR agonists Chemistry; Metallurgy 1 Active
US10906885B2 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 1 Active
US11034670B2 Poly-ADP ribose polymerase (PARP) inhibitors Chemistry; Metallurgy 1 Active
US11993585B2 Poly-ADP ribose polymerase (PARP) inhibitors Chemistry; Metallurgy 0 Active
US11912679B2 Aryl alkynamide derivatives Chemistry; Metallurgy 0 Active
US10188627B2 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 0 Active
US11420934B2 PPAR agonists Chemistry; Metallurgy 0 Active
US10968172B2 USP30 inhibitors Chemistry; Metallurgy 0 Active
US11358954B2 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 0 Active
US11912681B2 Crystalline and salt forms of PPAR agonist compounds Chemistry; Metallurgy 0 Active
US10874641B2 Methods of treating acute kidney injury Human Necessities 0 Active
US11168080B2 Dynamin-1-like protein inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.